These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15780826)

  • 1. Targeting survival signaling in heart failure.
    Morissette MR; Rosenzweig A
    Curr Opin Pharmacol; 2005 Apr; 5(2):165-70. PubMed ID: 15780826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs.
    Mollinedo F
    IDrugs; 2005 Feb; 8(2):127-43. PubMed ID: 15696415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocyte apoptosis in heart failure.
    van Empel VP; Bertrand AT; Hofstra L; Crijns HJ; Doevendans PA; De Windt LJ
    Cardiovasc Res; 2005 Jul; 67(1):21-9. PubMed ID: 15896727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and diseases: regulation and clinical relevance.
    Alenzi FQ
    Saudi Med J; 2005 Nov; 26(11):1679-90. PubMed ID: 16311648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuregulin-1/ErbB signaling: a druggable target for treating heart failure.
    Xu Y; Li X; Zhou M
    Curr Opin Pharmacol; 2009 Apr; 9(2):214-9. PubMed ID: 19070544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure.
    Lemmens K; Doggen K; De Keulenaer GW
    Circulation; 2007 Aug; 116(8):954-60. PubMed ID: 17709650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting apoptosis as an approach for gastrointestinal cancer therapy.
    Qiao L; Wong BC
    Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy.
    Henson ES; Gibson SB
    Cell Signal; 2006 Dec; 18(12):2089-97. PubMed ID: 16815674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy.
    Hoshijima M; Knöll R; Pashmforoush M; Chien KR
    J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ER stress-induced apoptosis: a novel therapeutic target in heart failure.
    Wang J; Hu X; Jiang H
    Int J Cardiol; 2014 Dec; 177(2):564-5. PubMed ID: 25179556
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in both death and survival signals for apoptosis in heart failure due to volume overload.
    Dent MR; Das S; Dhalla NS
    J Mol Cell Cardiol; 2007 Dec; 43(6):726-32. PubMed ID: 17931652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in hypertensive heart disease: a clinical approach.
    González A; Ravassa S; López B; Loperena I; Querejeta R; Díez J
    Curr Opin Cardiol; 2006 Jul; 21(4):288-94. PubMed ID: 16755196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
    Jazirehi AR; Bonavida B
    Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Nguyen and Doenst regarding article "Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart-failure prone rat".
    Nguyen TD; Doenst T
    Circ Heart Fail; 2009 May; 2(3):e1; author reply e2. PubMed ID: 19808332
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiomyocyte apoptosis in the failing heart--a critical review from definition and classification of cell death.
    Takemura G; Kanoh M; Minatoguchi S; Fujiwara H
    Int J Cardiol; 2013 Sep; 167(6):2373-86. PubMed ID: 23498286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
    Feng QZ; Zhao YS; Abdelwahid E
    Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-kappaB-mediated survival signaling.
    Leskinen MJ; Heikkilä HM; Speer MY; Hakala JK; Laine M; Kovanen PT; Lindstedt KA
    Exp Cell Res; 2006 May; 312(8):1289-98. PubMed ID: 16460729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.